Clinical trials
Terminated Thrombocythemia, Essential trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CTI BioPharma | 2 |
| M.D. Anderson Cancer Center | 2 |
| Mayo Clinic | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Baylor College of Medicine | 1 |
| City of Hope Medical Center | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Exelixis | 1 |
| Fred Hutchinson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 25 |
| Polycythemia Vera | 23 |
| Primary Myelofibrosis | 21 |
| Myeloproliferative Disorders | 20 |
| Leukemia | 10 |
| Leukemia, Myeloid, Acute | 10 |
| Leukemia, Myelomonocytic, Chronic | 9 |
| Myelodysplastic Syndromes | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 8 |
Trials
Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.